Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.
about
A novel method for constructing continuous intrinsic surfaces of nanoparticles.Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor.
P2860
Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@ast
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@en
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@nl
type
label
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@ast
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@en
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@nl
prefLabel
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@ast
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@en
Nanoparticle delivery of an AK ...... c effect in pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Nanoparticle delivery of an AK ...... ic effect in pancreatic cancer
@en
P2093
Edward R Abril
Emmanuelle J Meuillet
Justin J Jeffery
Mark D Pagel
Raymond B Nagle
Roberto Guzman
P2860
P304
P356
10.2147/IJN.S68511
P407
P577
2014-12-03T00:00:00Z